Emma Lindhardt

Sorry, we do not have enough data to show an influence graph for this author.
Learn More
Model-based analysis of routinely generated pharmacokinetic and pharmacodynamic (PK-PD) data is a key component of preclinical drug discovery. The work process of such analyses can be automated by properly designed computer programs that reduce the number of manual steps, resulting in time saving and significantly fewer errors. Critical decisions can still(More)
  • 1